Latest Commercialisation News

Calix's subsidiary Leilac has locked in a paid engineering study with an East Asian cement producer, advancing its commercial cement decarbonisation technology without capital outlay. This complements its recent Indian partnership and signals a strategic pivot to capital-light projects.

Environmental Clean Technologies (ASX: ECT) has submitted detailed data to the US EPA showcasing its Rapid Electrothermal Mineralisation (REM) technology's ability to destroy PFAS with over 99% efficacy and full fluorine mass balance, aiming to meet stringent regulatory standards.

Iondrive Limited has gained a significant boost from the Oklahoma Department of Commerce, receiving a Letter of Support and potential incentives valued at over US$15 million for scaling its rare earth recycling modules in the US.

Lion Energy has locked in Indonesian government approval for a key farm-out deal, enabling OPIC to fund the majority of the Bula Karang-1 well costs while Lion retains a significant stake in the East Seram PSC.

Altech Batteries has sold its non-core land in Meckering, Western Australia, for $950,000, boosting working capital while retaining mining rights. The sale also triggered a $500,000 bank guarantee tied to €2 million bearer bonds due in October.

Neuren’s partner Acadia secures positive CHMP opinion for DAYBU® in Rett syndrome, paving the way for first EU treatment approval and triggering significant milestone payments for Neuren.

Recce Pharmaceuticals secured A$4 million through an institutional placement and launched a Share Purchase Plan to raise up to an additional A$4 million, bolstering funds for commercial licensing and ongoing clinical programs.

1414 Degrees offers bonus Loyalty Options to shareholders alongside a $8.45 million capital raise aimed at advancing its clean energy projects, including the Aurora Energy Precinct and SiNTL commercialisation.

FortifAI has appointed David Walker and Tim Edwards to its newly formed Advisory Board, reinforcing its push towards the commercial launch of the Nol8 AI Data Plane. These appointments bring heavyweight technology and financial services expertise to the company as it scales.

Skin Elements Limited has secured a $900,000 placement at a 25% discount to recent prices, bolstering its balance sheet to advance its natural biotechnology product range. The company also appointed Rod Nicholas as non-executive chairman and engaged Phoenix Global Investments for investor relations.

Swoop Holdings has agreed to sell its Melbourne Fibre Project subsidiary to Singapore-based Xenith Infrastructure Group for $11 million plus project cost reimbursements. The deal offloads remaining capital commitments and will help reduce Swoop’s debt.

Control Bionics has locked in $9.5 million through a discounted share placement, complemented by a $0.5 million Share Purchase Plan, to back its commercial growth and technology development.